Literature DB >> 23198900

Dermoscopy of apocrine hidrocystomas: a morphological study.

P Zaballos1, J Bañuls, C Medina, E Salsench, P Serrano, N Guionnet.   

Abstract

BACKGROUND: The dermoscopic morphology of apocrine hidrocystomas remains to be elucidated.
OBJECTIVE: To evaluate the morphological findings of apocrine hidrocystomas under dermoscopic observation.
METHODS: Dermoscopic examination of 22 cases of apocrine hidrocystomas was performed to evaluate specific dermoscopic criteria and patterns.
RESULTS: The most frequently occurring dermoscopic features were found to be: (i) A translucent to opaque, homogeneous area which occupies the whole lesion in all apocrine hidrocystomas (100%). The colour of this homogeneous area was skin-colored in 31.8% of our cases; yellow, in 31.8% and blue, in 22.7% of apocrine hidrocystomas. (ii) Vascular structures were identified in 81.8% of our cases; arborizing vessels, in 68.2% and linear-irregular vessels in 9.1% of our cases; and (iii) Whitish structures were identified in 22.7% of the lesions. The results of our study reveal that the presence of a homogeneous area that occupies the whole lesion and arborizing vessels is the most common dermoscopic pattern in apocrine hidrocystomas (68.2%).
CONCLUSION: Apocrine hidrocystomas, above all in its pigmented variant, may represent a dermoscopic pitfall, being difficult to differentiate clinically and dermoscopically from basal cell carcinomas.
© 2012 The Authors. Journal of the European Academy of Dermatology and Venereology © 2012 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2012        PMID: 23198900     DOI: 10.1111/jdv.12044

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  10 in total

1.  Eccrine Hidrocystoma of the Central Chest and Dermoscopic Findings.

Authors:  Anna M Zanot; Jaime Tschen; Sirunya Silapunt
Journal:  Cureus       Date:  2020-05-07

2.  Dermoscopy as an Aid in the Differentiation of Recurrent Eyelid Basal Cell Carcinoma Versus apocrine Hidrocystoma.

Authors:  Leonel Hidalgo; Eugenia Abusleme; Cristián Navarrete-Dechent; Álvaro Abarzúa-Araya
Journal:  Dermatol Pract Concept       Date:  2022-04-01

3.  Eccrine Hidrocystoma: A Report of Two Cases with Special Reference to Dermoscopic Features.

Authors:  Pradeep Kumar; Vijay Gandhi; Priti Kumari
Journal:  J Cutan Aesthet Surg       Date:  2021 Jan-Mar

4.  Pale halo surrounding a homogeneous bluish-purplish central area: dermoscopic clue for eccrine hidrocystoma.

Authors:  Nilay Duman; Deniz Duman; Sedef Sahin
Journal:  Dermatol Pract Concept       Date:  2015-10-31

5.  Dermoscopy of a rare case of linear syringocystadenoma papilliferum with review of the literature.

Authors:  Payal Chauhan; Rishabh Kumar Chauhan; Amrita Upadhyaya; Sanjeev Kishore
Journal:  Dermatol Pract Concept       Date:  2018-01-31

6.  Dermoscopy of Eccrine Hidrocystomas.

Authors:  Ananta Khurana; Purnima Malhotra; R K Gautam
Journal:  Indian Dermatol Online J       Date:  2018 Jul-Aug

7.  What could this dark lesion on a woman's eyelid be?

Authors:  Maria Victoria Rosso; Maria Victoria Rodriguez Kowalczuk; Maria Manuela Martinez Piva; Luis Daniel Mazzuoccolo
Journal:  Int J Womens Dermatol       Date:  2022-08-24

8.  Dermoscopic Features of A Case of Intradermal Nevus with Foreign Body Granulomatous Inflammation.

Authors:  Biswanath Behera; Rashmi Kumari; Devinder Mohan Thappa; Debasis Gochhait
Journal:  Indian Dermatol Online J       Date:  2020-01-24

Review 9.  Dermoscopy of cutaneous adnexal tumours: a systematic review of the literature.

Authors:  M Lai; M Muscianese; S Piana; J Chester; S Borsari; G Paolino; G Pellacani; C Longo; R Pampena
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-05-25       Impact factor: 9.228

10.  Arborizing Vessels on Dermoscopy in Various Skin Diseases Other Than Basal Cell Carcinoma.

Authors:  Hyunju Jin; Min-Young Yang; Jeong-Min Kim; Gun-Wook Kim; Hoon-Soo Kim; Hyun-Chang Ko; Byung-Soo Kim; Moon-Bum Kim
Journal:  Ann Dermatol       Date:  2017-05-11       Impact factor: 1.444

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.